Byong Duk Ye

A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia

Suk‐Kyun Yang, Myunghee Hong, Jiwon Baek et al. · Nature Genetics · 2014 · 535 citations · Full text

Inflammation, Cytokine, Anti-inflammatory +9

Randomized Controlled Trial: Subcutaneous vs Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease

Stefan Schreiber, Shomron Ben‐Horin, Jarosław Leszczyszyn et al. · Gastroenterology · 2021 · 216 citations

Inflammation, Anti-inflammatory, Controlled Trial +5

Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study

Byong Duk Ye, Marina Pesegova, Olga Alexeeva et al. · The Lancet · 2019 · 203 citations · Full text

Biosimilar Ct-p13, Originator Infliximab, Gastroenterology +5

Genome-wide association study of Crohn's disease in Koreans revealed three new susceptibility loci and common attributes of genetic susceptibility across ethnic populations

Suk‐Kyun Yang, Myunghee Hong, Wanting Zhao et al. · Gut · 2013 · 183 citations · Full text

A 30-year Trend Analysis in the Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District of Seoul, Korea in 1986–2015

Sang Hyoung Park, Ye‐Jee Kim, Kyoung Hoon Rhee et al. · Journal of Crohn s and Colitis · 2019 · 160 citations